Neulasta Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
Condition:   Biliary Atresia Intervention:   Drug: Filgrastim Sponsors:   Holterman, Ai-Xuan, M.D.;   T Rose Clinical, Inc.;   Big Leap Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2020 Category: Research Source Type: clinical trials

CLAG-M Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Conditions:   Acute Leukemia of Ambiguous Lineage;   Recurrent Acute Myeloid Leukemia;   Recurrent Acute Undifferentiated Leukemia;   Recurrent Chronic Myelomonocytic Leukemia;   Recurrent Mixed Phenotype Acute Leukemia;   Recurrent Myelodysplastic Syndrome;   Refractory Acute Myelo id Leukemia;   Refractory Chronic Myelomonocytic Leukemia;   Refractory Mixed Phenotype Acute Leukemia;   Refractory Myelodysplastic Syndrome Interventions:   Drug: Cladribine;   Drug: Cyclophosphamide;   Drug: Cyclosporine;   Drug: Cytarabine;   Biological: Filgrastim;   Procedure: Hematopoi...
Source: ClinicalTrials.gov - May 5, 2020 Category: Research Source Type: clinical trials

Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
Condition:   Biliary Atresia Intervention:   Drug: Filgrastim Sponsors:   Holterman, Ai-Xuan, M.D.;   T Rose Clinical, Inc.;   Big Leap Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2020 Category: Research Source Type: clinical trials

CLAG-M Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Conditions:   Acute Leukemia of Ambiguous Lineage;   Recurrent Acute Myeloid Leukemia;   Recurrent Acute Undifferentiated Leukemia;   Recurrent Chronic Myelomonocytic Leukemia;   Recurrent Mixed Phenotype Acute Leukemia;   Recurrent Myelodysplastic Syndrome;   Refractory Acute Myelo id Leukemia;   Refractory Chronic Myelomonocytic Leukemia;   Refractory Mixed Phenotype Acute Leukemia;   Refractory Myelodysplastic Syndrome Interventions:   Drug: Cladribine;   Drug: Cyclophosphamide;   Drug: Cyclosporine;   Drug: Cytarabine;   Biological: Filgrastim;   Procedure: Hematopoi...
Source: ClinicalTrials.gov - May 5, 2020 Category: Research Source Type: clinical trials

Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
Condition:   Biliary Atresia Intervention:   Drug: Filgrastim Sponsors:   Holterman, Ai-Xuan, M.D.;   T Rose Clinical, Inc.;   Big Leap Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2020 Category: Research Source Type: clinical trials